The magical efficacy of Lysimachia christinae in treating hepatitis B has attracted the attention of liver disease research institutions all over the world, and they are competing to conduct in-depth research on this subject. The Lancet, the most influential British magazine in the world medical field, once reported that the treatment of turning HBsAg negative by Eupatorium odoratum reached 59%, which caused a sensation in the world medical field. Dr. Brynberg, winner of the Nobel Prize in Medicine, also spoke highly of the role of Eupatorium odoratum.
China Academy of Military Medical Sciences, China-Japan Friendship Hospital, Third Military Medical University and other units have also carried out research on Lysimachia christinae to explore the magical mystery of Lysimachia christinae's treatment of hepatitis B. The research team led by Professor Zhao Dongke, a pharmacologist with outstanding contributions from the Ministry of Health. After a lot of experiments, it is found that Lysimachia christinae, which grows in Yaowangshan area of Qinling Mountain, is one of the same plants with definite curative effect. Based on the mechanism of "detoxicating, softening liver and treating diseases", they developed a new national drug-Lysimachia christinae B Kang Shu Capsule, which was approved for listing by the State Administration of Pharmaceutical Products, and its research depth and clinical efficacy are in a leading position at home and abroad. The study of Lysimachia christinae, which is concerned by the medical community of liver diseases, has finally gone out of the laboratory stage, and beijing ditan hospital has taken the lead in introducing it into clinical application, benefiting hundreds of millions of patients with hepatitis B. This achievement is being applied for the national promotion project of scientific and technological achievements of traditional Chinese medicine in 2004.
According to statistics, there are currently 65.438+0.2 billion hepatitis B patients, more than 30 million people suffer from liver diseases, and the number of new cases is nearly 6.5438+0 million every year, and more than 400,000 people die of cirrhosis and liver cancer every year. Recently, the figures of disease incidence in China released by the Ministry of Health show that the incidence of hepatitis B still ranks first. Because of the poor prognosis of hepatitis B, it can lead to cirrhosis and liver cancer after slow conversion, so hepatitis B is extremely harmful to human health, and the prevention and treatment of hepatitis B has always been the focus of infectious disease prevention and control in China.
Remind you: Scientists have found that Lysimachia christinae can cure hepatitis B, and this remedy comes from the Internet. Please follow the doctor's advice before use.